Sat Kartar Life Submits FY26 Earnings Call Transcript With Strategic Growth Roadmap
Published on: May 10, 2026, 4:59 a.m. | Source: scanx.trade
Sat Kartar Life Limited filed the transcript of its H2 and FY26 Earnings Conference Call with NSE under Regulation 30 of SEBI (LODR) Regulations 2015. Management reported 23% revenue growth crossing ₹200 crore, 73% EBITDA growth, and 74% PAT growth for FY26, while outlining a dual-engine growth strategy combining its core Ayurveda product business with a new hospital vertical targeting 300 beds by FY27 end and 1,000 beds by FY28, supported by a non-exclusive partnership with Jeena Sikho and ongoing expansion into the US market through its Plantomed subsidiary.
